
A six-month acceleration programme tailored for market-validated startups seeking to refine their business models, scale internationally, and raise strategic investment. The programme offers up to €250,000 in combined funding and support, delivered through a structured blend of 1-on-1 mentorship, hands-on sales enablement, business development, and access to a powerful network of partners, distributors, and investors. Designed for startups in Fintech, Health, Biotechnology, FMCG, and PET sectors, the service focuses on accelerating commercial traction and unlocking new growth opportunities. Startups are selected through a competitive process and receive personalised support from in-house and external experts, including experienced founders, domain specialists, and active investors. Key activities include lead mentor sessions, tailored advisory meetings, market access sprints and curated investor introduction. Participants gain tactical support in sales strategy, business model evolution, and international expansion. By the end of the programme, participating companies are expected to have refined their business models and secured new commercial or investment leads. The programme is delivered in Belgrade through a hybrid format and hosts four startups per six months.
Equity based model , typically 1–15%, in exchange for support services.
Participation is based on a selection process. Terms and cohort schedules are subject to updates based on market conditions.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.